Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-1,41%
1 076,13
-15,38
-1,41%
1 091,511 090,401 090,401 073,69
SIXC
Communications
SIXC
Communications
SIXC
-0,55%
606,74
-3,37
-0,55%
610,11610,11610,29606,17
SIXE
Energy
SIXE
Energy
SIXE
+0,88%
1 248,82
+10,84
+0,88%
1 237,981 237,831 252,411 225,03
SIXI
Industrials
SIXI
Industrials
SIXI
-1,17%
1 724,36
-20,35
-1,17%
1 744,711 740,951 747,291 721,57
SIXM
Financials
SIXM
Financials
SIXM
-0,72%
635,59
-4,59
-0,72%
640,18639,92643,19634,73
SIXR
Staples
SIXR
Staples
SIXR
-0,76%
843,15
-6,43
-0,76%
849,58845,27851,68839,47
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0,55%
216,29
-1,19
-0,55%
217,48217,48218,16215,51
SIXT
Technology
SIXT
Technology
SIXT
+0,08%
3 263,41
+2,72
+0,08%
3 260,693 273,363 287,813 240,78
SIXU
Utilities
SIXU
Utilities
SIXU
-0,34%
939,24
-3,21
-0,34%
942,45939,39948,80933,98
SIXV
Health care
SIXV
Health care
SIXV
-0,29%
1 462,56
-4,24
-0,29%
1 466,801 464,701 467,191 458,36
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0,71%
2 380,40
-17,10
-0,71%
2 397,502 395,032 412,012 370,64
ALKEM:NSE
Alkem Laboratories Ltd
5 381,00 INR
-0,35%
(-19,00) 1D
4 მაი, 15:30:01 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for ALKEM...
Open
5 382,00 INR
High
5 393,50 INR
Low
5 316,00 INR
Mkt. cap
643,38 მლრ.
Avg. vol.
107,34 ათ.
Volume
103,60 ათ.
Dividend
0,95%
Quarterly dividend
12,75 INR
Ex dividend date
14 თებ. 2025
P/E ratio
27,13
52-wk high
5 933,50 INR
52-wk low
4 716,20 INR
EPS
198,32 INR
Shares outstanding
119,55 მლნ.
No. of employees
19 ათ.
News stories
From sources across the web
Profile
Alkem Laboratories Limited is an Indian multinational pharmaceutical company headquartered in Mumbai. Specialising in generics and speciality pharmaceuticals, Alkem manufactures and markets pharmaceutical generics, formulations and nutraceuticals across India and global markets. Wikipedia
About Alkem Laboratories Ltd
CEO-
Employees18,8 ათ.
Founded1973
Headquartersმუმბაი, მაჰარაშტრა, ინდოეთი
SectorPharmaceutical industry
Last report
13 თებ. 2026
Fiscal Period
Q3 2026
Normalized EPS / Estimate
56,88/ (57,97 est.)INR
-1,88%miss
Revenue / Estimate
37,37 მლრდ./ (37,61 მლრდ. est.)INR
-0,64%miss
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
მარ. 2025
ივნ. 2025
სექ. 2025
დეკ. 2025
Revenue
31,44 მლრდ.
33,71 მლრდ.
40,01 მლრდ.
37,37 მლრდ.
Cost of goods sold
14,40 მლრდ.
11,71 მლრდ.
14,01 მლრდ.
12,73 მლრდ.
Cost of revenue
14,40 მლრდ.
11,71 მლრდ.
14,01 მლრდ.
12,73 მლრდ.
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
14,05 მლრდ.
6,93 მლრდ.
7,10 მლრდ.
7,22 მლრდ.
Operating expense
14,28 მლრდ.
15,49 მლრდ.
17,73 მლრდ.
17,31 მლრდ.
Total operating expenses
28,68 მლრდ.
27,20 მლრდ.
31,74 მლრდ.
30,04 მლრდ.
Operating income
2,76 მლრდ.
6,51 მლრდ.
8,27 მლრდ.
7,33 მლრდ.
Other non operating income
-3,24 მლრდ.
1,36 მლრდ.
1,04 მლრდ.
1,43 მლრდ.
EBT including unusual items
3,96 მლრდ.
7,71 მლრდ.
8,95 მლრდ.
7,81 მლრდ.
EBT excluding unusual items
3,36 მლრდ.
7,58 მლრდ.
8,95 მლრდ.
8,33 მლრდ.
Income tax expense
733,30 მლნ.
1,03 მლრდ.
1,16 მლრდ.
1,28 მლრდ.
Effective tax rate
18,53%
13,33%
12,98%
16,35%
Other operating expenses
-894,30 მლნ.
7,68 მლრდ.
9,69 მლრდ.
9,15 მლრდ.
Net income
3,06 მლრდ.
6,64 მლრდ.
7,65 მლრდ.
6,36 მლრდ.
Net profit margin
9,73%
19,70%
19,12%
17,02%
Earnings per share
25,57
54,62
63,99
56,88
Interest and investment income
3,59 მლრდ.
-
-
-
Interest expense
-115,00 მლნ.
-297,80 მლნ.
-350,20 მლნ.
-421,00 მლნ.
Net interest expenses
3,47 მლრდ.
-297,80 მლნ.
-350,20 მლნ.
-421,00 მლნ.
Depreciation and amortization charges
1,12 მლრდ.
876,80 მლნ.
936,10 მლნ.
950,10 მლნ.
EBITDA
3,53 მლრდ.
7,29 მლრდ.
9,18 მლრდ.
8,11 მლრდ.
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more